PhaseV (Series A)
Funding Details
Awarder
Inbox
Date Award
May 16, 2025
Vertical
AI/ML-driven clinical development
Funding URL
View Funding Page
Funding Amount
$50,000,000
Company Info
Traction
PhaseV has delivered results for more than 30 leading pharma/biotech sponsors and CROs.
Market
Biopharma and CROs
Location
Boston, MA, USA
Coinvestors
Accel, Insight Partners, Viola Ventures, EXOR, LionBird
Company Description

PhaseV is developing advanced AI/ML solutions to optimize clinical development. Their platform helps biopharma sponsors and CROs design and execute clinical trials efficiently, analyze data for treatment effects, and inform R&D decisions.

Links
Website
Back to HomeBack to AI/ML-driven clinical development DealsView Funding Announcement